Adjuvant treatment decisions for patients with endometrial cancer in Germany: results of the nationwide AGO pattern of care studies from the years 2013, 2009 and 2006
| Autor: | Marco Johannes Battista, Marcus Schmidt, Eric Steiner, Michael Eichbaum, Isabel Sicking, Heinz Koelbl, Nicole Rieks, Peter Mallmann, Stefan Albrich, G Hoffmann |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Time Factors medicine.medical_treatment Brachytherapy Decision Making MEDLINE Surveys and Questionnaires Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Carcinoma Humans External beam radiotherapy Practice Patterns Physicians' Neoplasm Staging Health Services Needs and Demand business.industry Endometrial cancer General Medicine Guideline Prognosis medicine.disease Carcinoma Papillary Cystadenocarcinoma Serous Endometrial Neoplasms Radiation therapy Exact test Chemotherapy Adjuvant Vagina Female Radiotherapy Adjuvant Guideline Adherence business Follow-Up Studies |
| Zdroj: | Journal of Cancer Research and Clinical Oncology. 141:555-562 |
| ISSN: | 1432-1335 0171-5216 |
| DOI: | 10.1007/s00432-014-1834-9 |
| Popis: | In 2013, 2009 and 2006, the Arbeitsgemeinschaft Gynakologische Onkologie evaluated the therapeutic approaches for endometrial carcinoma and the adherence to their guideline in Germany. Here, the adjuvant treatment decisions were presented. A questionnaire was developed and sent to all 682 German gynecological departments in 2013 (775 in 2009 and 500 in 2006, respectively). The results of the questionnaires were compared with the recommendations of the guideline and with each other using Fisher’s exact test. Responses were available in 40.0 % in 2013, 33.3 % in 2009 and 35.8 % in 2006. Participants recommended external beam radiotherapy (EBRT) in 13 out of 16 requested stages and vaginal brachytherapy (VBT) in only 10 out of 16 requested stages as suggested by the guideline. Comparing the results of 2013 with 2009, less participants used EBRT and VBT in 7 out of 16 and in 6 out of 16 requested stages, respectively. Conversely, more participants offered adjuvant chemotherapy (CT) in 2013 (90.4 %) compared to 61.9 % in 2009 (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink